12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Friday's after-market session. ContraFect, Exagen, Pasithea Therapeutics, Talaris Therapeutics, Renalytix, and GRI Bio saw their stocks rise, while Addex Therapeutics, Dyadic International, Sunshine Biopharma, Senti Biosciences, First Wave BioPharma, and Salarius Pharmaceuticals experienced a decline.
October 06, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ContraFect's stock rose 17.5% to $0.47 during Friday's after-market session.
The significant increase in ContraFect's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
GRI Bio's stock moved upwards by 8.85% to $1.72.
The significant increase in GRI Bio's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Pasithea Therapeutics' stock rose 15.0% to $0.46.
The significant increase in Pasithea Therapeutics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Renalytix's stock moved upwards by 8.94% to $1.34.
The significant increase in Renalytix's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Talaris Therapeutics' stock moved upwards by 10.25% to $2.98.
The significant increase in Talaris Therapeutics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Exagen's shares rose 15.63% to $2.44.
The significant increase in Exagen's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Addex Therapeutics' shares declined by 10.8% to $0.38.
The significant decrease in Addex Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Dyadic International's shares decreased by 9.81% to $1.84.
The significant decrease in Dyadic International's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
First Wave BioPharma's stock decreased by 5.55% to $0.31.
The significant decrease in First Wave BioPharma's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Sunshine Biopharma's shares decreased by 9.47% to $0.33.
The significant decrease in Sunshine Biopharma's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Salarius Pharmaceuticals' shares fell 5.17% to $0.62.
The significant decrease in Salarius Pharmaceuticals' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Senti Biosciences' stock fell 6.6% to $0.34.
The significant decrease in Senti Biosciences' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100